Skip to main content

Advertisement

Table 2 Distribution of marker values between patient and control groups

From: Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients

Mean ± SD Patient (n = 29) Control (n = 29) P
Osteocalcin (ng/mL) 25.55 ± 4.15 26.42 ± 3.33 0.881
Bone ALP (μg/L) 57.32 ± 46.83 34.57 ± 21.57 0.037
CTx (ng/mL) 1.19 ± 1.73 0.74 ± 0.32 0.193
25 (OH)D(ng/mL) 12.72 ± 7.44 12.06 ± 5.54 0.717
PTH (pg/mL) 42.97 ± 14.70 54.44 ± 57.26 0.350
  1. Analyzed by paired t-test
  2. SD standard deviation, ALP alkaline phosphatase, CTx serum collagen type 1 cross-linked C-telopeptide, PTH parathyroid hormone
  3. Significant P-values in bold letters